Nymox Pharmaceutical {NASDAQ: NYMX} shares have fallen sharply this week, losing one third of their value, after a Seeking Alpha article making some serious allegations against the company.
The company have not responded, but have announced progress in their drug development.
Comment
The Seeking Aplha article linked below has made some serious allegations against Nymox, and a NY based lawyer is issuing a Class Action Lawsuit against Nymox, and the company has not responded.
Under those circumstances it’s hard to continue following the stock until the situation becomes clearer, and we will desist, but may issue updates on the legal case moving forward.
The Seeking Alpha article can be read HERE
Bronstein-Gewirtz–Grossman investgation article is HERE
Block Leviton LLP investigation announced HERE